JRSIS Health Care Corp (JRSS) is a micro-cap China-based smart medical equipment and services company operating through a VIE structure (Yongzhou JIT, 85.53% controlled). The September 30, 2024 balance sheet shows total assets of $2.07M against total liabilities of $2.31M, producing consolidated stockholders' equity of negative $234K. Under the liquidation lens, the recovery posture is deeply negative. MFFAIS reports a cash liquidation value of negative $2.31M, liquid liquidation value of negative $1.73M, and operating liquidation value of negative $1.37M, all consistent with a face-value liability stack that overwhelms even optimistically haircut assets. Key drivers: (1) Cash is $1,372 — effectively zero. (2) Accounts receivable of $575K is concentrated 91% in a single customer (Customer A) for Q3 2024; at 90-95% recovery that yields ~$517-546K but collectability risk is elevated given single-counterparty concentration. (3) Inventory of $362K net (gross $410K less $48K reserve) applies at ~60% recovery = ~$217K. (4) PP&E net $43K yields at most $30K at 50-70% haircut. (5) Intangibles net $241K — zero liquidation value. Total haircut asset pool approximates $800-900K against $2.31M in face-value liabilities, confirming negative equity recovery of roughly $1.4-1.5M — consistent with the MFFAIS OLV figure. Since the prior filing (June 30, 2024 10-Q), short-term borrowings grew from approximately $983K to $1.31M (33% QoQ increase) driven by new draws from Bank of China and China Construction Bank. Accounts receivable from related parties surged $578K YTD per the cash flow statement, indicating a large portion of reported AR is intercompany or related-party with uncertain enforceability in liquidation. The working capital deficit widened to $512K at September 30, 2024 versus $404K at September 30, 2023. Management has disclosed substantial doubt about going concern. Operating cash outflow for the nine months was $826K versus $421K inflow for the same period in 2023 — a significant reversal. The filing discusses a $138K inventory impairment reversal in the nine-month cash flow but does not separately XBRL-tag the reversal breakdown; only the net InventoryWriteDown tag of negative $138K appears in the XBRL, indicating a reversal rather than a charge. The accumulated deficit stands at $3.88M. The VIE structure introduces an additional liquidation risk: contractual arrangements rather than direct equity ownership govern control of YZ JIT, and the NCI balance is itself negative at $37K, meaning the minority interest provides no buffer. RMB-denominated assets subject to currency remittance restrictions further compress repatriation-adjusted recovery.
▼ Community Notes